Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients

References

• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):1–8.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Ballew SH, Wang AY, et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):696–707.
   PubMed Web of Science ®Google Scholar
• GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733.
   PubMed Web of Science ®Google Scholar
• Yun HR, Joo YS, Kim HW, et al. Coronary artery calcification score and the progression of chronic kidney disease. J Am Soc Nephrol. 2022;33(8):1590–1601.
   PubMed Web of Science ®Google Scholar
• Gregg LP, Hedayati SS. Management of traditional cardiovascular risk factors in CKD: What are the data? Am J Kidney Dis. 2018;72(5):728–744.
   PubMed Web of Science ®Google Scholar
• Kim JS, Hwang HS. Vascular calcification in chronic kidney disease: distinct features of pathogenesis and clinical implication. Korean Circ J. 2021;51(12):961–982.
   PubMed Web of Science ®Google Scholar
• Wang XR, Zhang JJ, Xu XX, et al. Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail. 2019;41(1):244–256.
   PubMed Web of Science ®Google Scholar
• Li Y, Wright GL, Peterson JM. C1q/TNF-related protein 3 (CTRP3) function and regulation. Compr Physiol. 2017;7(3):863–878.
   PubMed Web of Science ®Google Scholar
• Moradi N, Fadaei R, Khamseh ME, et al. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function. PLOS One. 2019;14(4):e0215617.
   PubMed Web of Science ®Google Scholar
• Maghbooli Z, Hossein-Nezhad A, Khoshechin G, et al. Possible association between circulating CTRP3 and knee osteoarthritis in postmenopausal women. Aging Clin Exp Res. 2019;31(7):927–934.
   PubMed Web of Science ®Google Scholar
• Srivaths PR, Goldstein SL, Silverstein DM, et al. Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol. 2011;26(6):945–951.
   PubMed Web of Science ®Google Scholar
• Jimbo R, Kawakami-Mori F, Mu S, et al. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int. 2014;85(5):1103–1111.
   PubMed Web of Science ®Google Scholar
• Masai H, Joki N, Sugi K, et al. A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease. Atherosclerosis. 2013;226(1):228–233.
   PubMed Web of Science ®Google Scholar
• Căpuşa C, Stefan G, Stancu S, et al. Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients. Arch Med Sci. 2016;12(5):1015–1022.
   PubMed Web of Science ®Google Scholar
• Scialla JJ, Lau WL, Reilly MP, et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int. 2013;83(6):1159–1168.
   PubMed Web of Science ®Google Scholar
• Pillar R, G Lopes MG, Rocha LA, et al. Severe hypovitaminosis D in chronic kidney disease: association with blood pressure and coronary artery calcification. Hypertens Res. 2013;36(5):428–432.
   PubMed Web of Science ®Google Scholar
• Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749.
   PubMed Web of Science ®Google Scholar
• Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–832.
   PubMed Web of Science ®Google Scholar
• Rumberger JA, Brundage BH, Rader DJ, et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999;74(3):243–252.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang JY, Feng H, et al. Overexpression of C1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro. Arterioscler Thromb Vasc Biol. 2014;34(5):1002–1010.
   PubMed Web of Science ®Google Scholar
• Yavuz YC, Altınkaynak K, Sevinc C, et al. The cartonectin levels at different stages of chronic kidney disease and related factors. Ren Fail. 2019;41(1):42–46.
   PubMed Web of Science ®Google Scholar
• Choi KM, Hwang SY, Hong HC, et al. C1q/TNF-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome. Diabetes. 2012;61(11):2932–2936.
   PubMed Web of Science ®Google Scholar
• Desjardins L, Liabeuf S, Renard C, et al. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int. 2012;23(7):2017–2025.
   PubMed Web of Science ®Google Scholar
• Canney M, Djurdjev O, Tang M, et al. GFR-specific versus GFR-agnostic cutoffs for parathyroid hormone and fibroblast growth factor-23 in advanced chronic kidney disease. Am J Nephrol. 2019;50(2):105–114.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kim HY, Gu SW, et al. 25-Hydroxyvitamin D levels and vascular calcification in predialysis and dialysis patients with chronic kidney disease. Kidney Blood Press Res. 2012;35(5):349–354.
   PubMed Web of Science ®Google Scholar
• Fayed A, El Nokeety MM, Heikal AA, et al. Serum 25-hydroxyvitamin D level is negatively associated with serum phosphorus level among stage 3a-5 chronic kidney disease patients. Nefrologia. 2018;38(5):514–519.
   PubMed Web of Science ®Google Scholar
• Golüke NMS, Schoffelmeer MA, De Jonghe A, et al. Serum biomarkers for arterial calcification in humans: a systematic review. Bone Rep. 2022;17:101599.
   PubMedGoogle Scholar
• Ozkok A, Kekik C, Karahan GE, et al. FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients. BMC Nephrol. 2013;14:241.
   PubMed Web of Science ®Google Scholar
• García-Canton C, Bosch E, Ramírez A, et al. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. 2011;26(7):2250–2256.
   PubMed Web of Science ®Google Scholar
• Wolf RM, Steele KE, Peterson LA, et al. Lower circulating C1q/TNF-related protein-3 (CTRP3) levels are associated with obesity: a cross-sectional study. PLOS One. 2015;10(7):e0133955.
   PubMed Web of Science ®Google Scholar
• Wang S, Ling Y, Liang W, et al. Association of serum C1q/TNF-related protein-3 (CTRP-3) in patients with coronary artery disease. BMC Cardiovasc Disord. 2017;17(1):210.
   PubMedGoogle Scholar